Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mydecine Innovations Group Inc (OP: MYCOF )

0.0049 -0.0020 (-28.99%)
Streaming Delayed Price Updated: 10:51 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mydecine Innovations Group Inc

< Previous 1 2 3 4 5 6 7 Next >
Second-Chance Buying Opportunity With Psychedelic Stock Warrants
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive. 
Via Talk Markets
With Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly Accepted
Via FinancialNewsMedia
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
How This Psychedelic Company Could Lead A Turnaround For The Sector
Compass Pathways PLC (NASDAQ:CMPS) is often viewed as the leader in the psychedeli... 
Via Benzinga
Mydecine Unveils Four Psychedelic Drug Candidates
Mydecine Innovations Group (OTC:MYCOF), a Denver-based psychedelics research company... 
Via Benzinga
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Biotech Companies Driving Psychedelics Industry Forward with Key Research
Via FinancialNewsMedia
Psyched: Entheon Launches Psychedelics Genetic Test, Mydecine Unveils Psychedelic Drug Candidates, California Bill Passes Senate Committee
Entheon Biomedical Corp. announced the 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.